
SCHOTT Pharma Investor Relations Material
Latest events

Q2 2025
SCHOTT Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SCHOTT Pharma AG & Co. KGaA
Access all reports
SCHOTT Pharma AG & Co. KGaA specializes in developing, producing, and selling advanced drug containment and delivery solutions for the injectable drugs market. Catering to the pharmaceutical and biotechnology industries globally, the company offers a comprehensive portfolio that includes polymer and glass syringes, ampoules, vials, and cartridges. Notable products in its range include the syriQ series of glass and polymer syringes designed for various applications such as vaccines, biologics, aesthetic treatments, infusion therapy, and deep-cold applications, as well as the cartriQ and adaptiQ lines for cartridges and vials, respectively. It is headquartered in Mainz, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Key slides for SCHOTT Pharma AG & Co. KGaA


Q3 2024
SCHOTT Pharma AG & Co. KGaA


Q4 2024
SCHOTT Pharma AG & Co. KGaA
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
1SXP
Country
🇩🇪 Germany